DeVry Inc. (NYSE: DV), Adeona Pharmaceuticals (NYSE: AEN), Celsion Co. (NASDAQ: CLSN), Costar Group Inc (NASDAQ: CSGP) and Health Care REIT (NYSE: HCN) getting new coverage from analysts.
Credit Suisse (NYSE:CS) initiated coverage on DeVry Inc. (DV). They placed a “Neutral” rating and a price target of $36.00 on the company.
Chardan Capital Markets initiated coverage on Adeona Pharmaceuticals (AEN). They placed a “Buy” rating and a price target of $1.00 on the company.
Rodman & Renshaw initiated coverage on Celsion Co. (CLSN). They placed an “Outperform” rating and a price target of $6.00 on the company.
Needham & Company initiated coverage on Costar Group Inc. (CSGP). They placed a “Buy” rating and a price target of $70.00 on the company.
Barclays Capital initiated coverage on Health Care REIT (HCN). They placed an “Overweight” rating on the company.
Thursday, October 27, 2011
DeVry (DV) (AEN) (CLSN) (CSGP) (HCN) Get New Coverage
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment